Cangrelor Impurities

During percutaneous coronary intervention, cangrelor, a P2Y12 platelet receptor antagonist, is used to lower the risk of periprocedural myocardial infarction (MI), recurrent coronary revascularization, and stent thrombosis (ST).

Show
per page